Catalyst Wire Dossier Catalyst Wire Dossier

Ruxolitinib Cream with Phototherapy

ruxolitinib · Incyte Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ruxolitinib Cream with Phototherapy, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo [Phase 2]

See pricing